Acetyl-CoA carboxylase 1 regulates chondrocyte metabolic plasticity with divergent effects on articular cartilage pathology and growth plate development
Osteoarthritis (OA) is a leading cause of disability, yet effective disease-modifying treatments remain unavailable. Metabolic dysfunction is increasingly implicated in OA pathogenesis, although its contributions to cartilage degeneration remain incompletely understood. Here, we investigated the role of acetyl-CoA carboxylase 1 (ACC1, encoded by Acaca), a rate-limiting enzyme in de novo lipogenesis, in cartilage homeostasis and disease. We found that ACC1 expression was elevated in human and murine articular cartilage during aging and obesity. Cartilage-specific deletion of ACC1 attenuated obesity-associated OA in both male and female mice, reducing cartilage degeneration and pain-related sensitivity without substantially altering systemic metabolic responses to a high-fat diet. ACC1 deletion also reduced pain-related responses following anterior cruciate ligament rupture, with significant structural protection observed predominantly in females. Consistent with these genetic findings, pharmacological ACC inhibition attenuated obesity-exacerbated post-traumatic OA. In contrast, ACC1 deletion during early postnatal development severely disrupted growth plate organization in the long bone, impaired chondrocyte maturation, and reduced longitudinal bone growth, accompanied by subsequent impairment of trabecular bone architecture. Mechanistically, ACC1 deficiency reduced de novo lipogenesis and cellular malonyl-CoA levels, accompanied by widespread reductions in protein lysine malonylation. Quantitative malonylome profiling revealed decreased malonylation of key enzymes involved in glycolysis, pentose phosphate pathway, and TCA cycle, including catalytically relevant residues in GAPDH and Aldolase. These changes lead to increased activities of metabolic enzymes, enhanced glycolysis, and extensive remodeling of cellular energy and lipid metabolism. Together, these findings establish distinct roles for ACC1 in articular cartilage homeostasis and growth plate development, highlighting the therapeutic potential of targeting ACC1 in adult OA while underscoring its essential contribution to normal skeletal growth.
Authors
- Birgit Schilling (ORCID: https://orcid.org/0000-0001-9907-2749)
- Bent Brachvogel (ORCID: https://orcid.org/0000-0002-3923-0554)
- Xiaotian Feng (ORCID: https://orcid.org/0000-0001-8736-5536)
- Shivakumar R. Veerabhadraiah (ORCID: https://orcid.org/0000-0002-9353-4591)
- Anupama Binoy (ORCID: https://orcid.org/0000-0001-6425-9570)
- Martin‐Paul Agbaga (ORCID: https://orcid.org/0000-0002-1920-915X)
- Michael J. Jurynec (ORCID: https://orcid.org/0000-0003-2702-9164)
- Véronique Lefèbvre (ORCID: https://orcid.org/0000-0001-9916-8433)
- Vishwajeet Puri (ORCID: https://orcid.org/0000-0003-1303-8967)
- Huanhuan Liu (ORCID: https://orcid.org/0000-0003-1790-3073)
- Zhaoyang Liu (ORCID: https://orcid.org/0000-0002-8032-1167)
- Shadi Moradi
- Shouan Zhu
- Mengliang Zhang
- P. Christeen Fernando
- Grant Davis
Institutions
- University of Southern California (US)
- Children's Hospital of Philadelphia (US)
- Buck Institute for Research on Aging (US)
- University of Cologne (DE)
- University of Utah (US)
- Ohio University (US)
- University of Oklahoma Health Sciences Center (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.15.766862
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- preprint
Funders
- Yale University
- Rheumatology Research Foundation
- Osteopathic Heritage Foundation
- McMaster University
- Eidgenössische Technische Hochschule Zürich
- National Institutes of Health